Latest Publications
Improved Pharma Obtains DEA Registration for Schedules I – V
DEA registration allows Improved Pharma to support pharmaceutical development for all types of controlled substances. WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 19, 2022 Improved Pharma is pleased to announce their DEA registration for schedules I –Read more
Ritonavir Form III: Lightning strikes twice at the same time, 137 miles apart
WEST LAFAYETTE, Ind. (PRWEB)September 13, 2022 Developing new tools and advancing pharmaceutical development is a key part of Improved Pharma’s mission. In 2021, Improved Pharma had the unique opportunity to start polymorph screening researchRead more
Identification of unknown crystals in a Vicks® DayQuil Severe LiquiCap
Crystals were observed growing within a DayQuil Liquicap. This blog post describes the approach taken to isolate and identify the unknown crystals. Vicks® DayQuil™ Severe Cold & Flu provides an over the counter non-drowsy,Read more
Improved Pharma at AAPS with Posters and Booth
Come see us at booth 555 and posters T1430-08-45 and T1430-08-46 Improved Pharma will be exhibiting in booth 555, conveniently located next to the 360 Center Stage. Also, Dr. Susan Bogdanowich-Knipp and Dr. PamelaRead more
Improved Pharma announces new collaboration with Keystone Pharma Consulting
WEST LAFAYETTE, Ind. (PRWEB)May 11, 2022 Improved Pharma is pleased to announce a collaboration with Dr. Patricia Andres from Keystone Pharma Consulting, LLC, thus further expanding its network of pharmaceutical consultants with expertise inRead more
Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs
Thermodynamic stability and form selection. Form selection of active pharmaceutical ingredients is regarded as an essential part of drug development. The goal of form selection is to identify the most suitable solid form forRead more